Real-world anti-amyloid therapy beyond traditional symptomatic populations: a longitudinal case series.

Han J, Fang Y, Esiaka D, Abraham O

DOI: 10.3389/fpsyt.2026.1900651
Published: 2026
Container: Frontiers in psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2026.1900651,
  title = {Real-world anti-amyloid therapy beyond traditional symptomatic populations: a longitudinal case series.},
  author = {Han J and Fang Y and Esiaka D and Abraham O},
  year = {2026},
  journal = {Frontiers in psychiatry},
  doi = {10.3389/fpsyt.2026.1900651},
  url = {https://doi.org/10.3389/fpsyt.2026.1900651}
}

RIS

TY  - JOUR
TI  - Real-world anti-amyloid therapy beyond traditional symptomatic populations: a longitudinal case series.
AU  - Han J
AU  - Fang Y
AU  - Esiaka D
AU  - Abraham O
PY  - 2026
JO  - Frontiers in psychiatry
DO  - 10.3389/fpsyt.2026.1900651
UR  - https://doi.org/10.3389/fpsyt.2026.1900651
ER  -

APA

J, H., Y, F., D, E., & O, A. (2026). Real-world anti-amyloid therapy beyond traditional symptomatic populations: a longitudinal case series.. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2026.1900651

Source records

pubmed · retrieved 2026-09-25T09:28:04.455Z